In February, we added 119 citations in DIDB, including 57 in vitro (with 21 articles published in February 2024) and 62 in vivo articles (with 35 articles published in February 2024).
4 NDAs approved in 2023 and 1 NDA approved in 2024, including berdazimer (ZELSUVMI), birch triterpenes (FILSUVEZ), eplontersen (WAIHUA), iptacopan (FABHALTA), zuranolone (ZURZUVAE), were also curated in DIDB.
We are pleased to let you know that all the NDAs and BLAs approved in 2023 (n = 55) have been entered in DIDB.
You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.
As always, feel free to contact us if you have any questions or comments.